/PRNewswire/ Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today three new appointments to.
/PRNewswire/ Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today the appointment of Jay A..
LEXEO Therapeutics Announces Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of AAV-based Gene Therapy Candidate LX1001 in Patients with Alzheimer’s Disease - read this article along with other careers information, tips and advice on BioSpace